Structures by: Rolland M.
Total: 27
C30H22Br2O6P2
C30H22Br2O6P2
Organic letters (2017)
a=27.0189(6)Å b=14.0226(4)Å c=7.2637(2)Å
α=90° β=90° γ=90°
C30H66Ga4N6O12,4(CHCl3)
C30H66Ga4N6O12,4(CHCl3)
Dalton Transactions (2009) 14 2569-2577
a=25.5428(12)Å b=13.1025(3)Å c=21.0117(10)Å
α=90° β=124.017(7)° γ=90°
C30H66In4N6O12,6(CHCl3)
C30H66In4N6O12,6(CHCl3)
Dalton Transactions (2009) 14 2569-2577
a=11.33520(29)Å b=11.43510(29)Å c=14.60850(40)Å
α=74.8165(17)° β=89.7859(16)° γ=70.8371(17)°
C30H66Fe4N6O12,6(CHCl3)
C30H66Fe4N6O12,6(CHCl3)
RSC Adv. (2015)
a=11.4770(12)Å b=11.4866(10)Å c=14.2984(16)Å
α=89.101(8)° β=74.396(10)° γ=70.145(9)°
C30H66Fe4N6O12,6(CHCl3)
C30H66Fe4N6O12,6(CHCl3)
RSC Adv. (2015)
a=11.38590(20)Å b=13.76370(29)Å c=22.75380(40)Å
α=87.8178(10)° β=80.2066(11)° γ=76.4053(11)°
(2R,3S,5S)-3,5-diphenyl-2-(4-methoxyphenyl)- [1,4,2]-oxazaphosphorinane2-oxide
C22H22N1O3P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=10.0104(3)Å b=8.10560(10)Å c=12.5372(3)Å
α=90° β=109.717(5)° γ=90°
(2S,3S,5S)-2,3,5-triphenyl-[1,4,2]-oxazaphosphorinane 2-oxide
C21H20N1O2P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=5.6212(6)Å b=25.714(2)Å c=13.561(2)Å
α=90° β=90° γ=90°
(2R,3S,5S)-3,5-diphenyl-[1,4,2]-oxazaphosphorinane 2-oxide.
C15H16N1O2P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=5.3914(2)Å b=11.7559(4)Å c=21.6032(8)Å
α=90° β=90° γ=90°
(2S,4S,5R)and(2R,4R,5S)-3-tert-butyl-2-ethyl-4,5- diphenyl-[1,3,2]-oxazaphospholidine2-oxide
C20H26NO2P
Acta Crystallographica Section B (2008) 64, 2 196-205
a=6.7231(5)Å b=11.9766(6)Å c=23.6865(16)Å
α=97.644(3)° β=93.038(2)° γ=98.742(2)°
(2S,4S,5R)-3-tert-butyl-2-[(1S)-1-?uoro-1-methyl- 2-oxo-propyl]-4,5-diphenyl-[1,3,2]-oxazaphospholidine2- oxide
C22H27F1N1O3P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=6.411(2)Å b=16.206(4)Å c=21.242(5)Å
α=90° β=99.51(2)° γ=90°
(2R,4R,5S)-3-tert-butyl-2-[(1S)-1-fluoro-1-methyl- 2-oxo-propyl]-4,5-diphenyl-[1,3,2]-oxazaphospholidine2- oxide.
C22H27F1N1O3P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=19.252(2)Å b=6.5840(10)Å c=17.295(2)Å
α=90° β=101.73(2)° γ=90°
(2R,4S,5R)-3-tert-butyl-2-benzyl-4,5-diphenyl- [1,3,2]-oxazaphospholidine2-oxide
C25H28N1O2P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=10.284(2)Å b=21.262(4)Å c=12.768(2)Å
α=90° β=119.04(2)° γ=90°
[2-(tertbutylcarbonylmethyl-amino]-phenyl)acetic acid
C14H19NO4
Acta Crystallographica Section E (2003) 59, 1 o4-o6
a=12.6392(6)Å b=5.1470(2)Å c=22.54500(10)Å
α=90.00° β=107.744(3)° γ=90.00°
2,2':6',2'':6'',2'''-quaterpyridine
C20H14N4
Acta Crystallographica Section E (2005) 61, 6 o1880-o1882
a=15.327(2)Å b=12.436(2)Å c=8.543(2)Å
α=90.00° β=113.50(2)° γ=90.00°
C16H23NO4
C16H23NO4
Acta Crystallographica Section C (2000) 56, 8 1037-1039
a=11.0434(5)Å b=11.0028(3)Å c=12.7460(6)Å
α=90.0000(10)° β=90.0000(10)° γ=90.0000(10)°
C16H23NO3
C16H23NO3
Acta Crystallographica Section C (2000) 56, 8 1037-1039
a=8.2610(3)Å b=12.5168(5)Å c=14.9291(3)Å
α=90.0000(10)° β=90.0000(10)° γ=90.0000(10)°
Dimethyl 3-benzyl-2-(4-methyl-2,5-dioxoimidazolidin-1-yl)butanedioate
C17H20N2O6
Acta Crystallographica Section C (2001) 57, 1 62-63
a=11.0323(7)Å b=11.7742(4)Å c=14.1121(9)Å
α=90° β=99.380(2)° γ=90°
(2'R,3'R,5'R,2S,3S)-3-bromomethyl-3-hydroxy-2-[(2'-hydroxy-2',6',6'- trimethylbicyclo[3.1.1]hept-3'-ylidene)amino]succinic acid
C21H34BrNO6
Acta Crystallographica Section C (2003) 59, 8 o473-o475
a=11.546(2)Å b=10.321(3)Å c=11.594(4)Å
α=90.00° β=118.031(5)° γ=90.00°
2,3,5,6,7,8-Hexahydro-6,8-methano-7,7,8a-trimethyl-3-(1-methyl-2- oxopropylidene)-5H-1,4-benzoxazin-2-one
C16H21NO3
Acta Crystallographica Section C (2001) 57, 12 1415-1417
a=8.4160(3)Å b=12.3127(5)Å c=14.7039(4)Å
α=90° β=90° γ=90°
2,3,5,6,7,8-Hexahydro-3-(2-hydroxy-1-methylpropyl)-6,8-methano-7,7,8a- trimethyl-5H-1,4-benzoxazin-2-one
C16H25NO3
Acta Crystallographica Section C (2001) 57, 12 1415-1417
a=10.2905(3)Å b=11.8864(5)Å c=12.8317(5)Å
α=90° β=90° γ=90°
C23H20FNO6
C23H20FNO6
Acta Crystallographica Section C (2000) 56, 4 445-447
a=9.5666(3)Å b=11.1026(2)Å c=20.3200(6)Å
α=90.000(10)° β=90.000(10)° γ=90.000(10)°
C25H25N1O8,0.5C4H8O2
C25H25N1O8,0.5C4H8O2
Acta Crystallographica Section C (2000) 56, 4 445-447
a=11.5600(10)Å b=8.4000(10)Å c=13.9540(10)Å
α=90.000(10)° β=103.410(10)° γ=90.000(10)°
Dibenzyl 2-benzyl-2-hydroxy-3-(4-methylphenylsulfonamido)succinate
C32H31NO7S
Acta Crystallographica Section C (2011) 67, 8 o301-o305
a=10.8712(4)Å b=19.8539(6)Å c=13.8180(4)Å
α=90.00° β=105.156(3)° γ=90.00°
Dibenzyl 2-benzyl-2-hydroxy-3-(4-methylphenylsulfonamido)succinate
C32H31NO7S
Acta Crystallographica Section C (2011) 67, 8 o301-o305
a=10.8577(4)Å b=11.1342(6)Å c=12.3719(6)Å
α=87.928(4)° β=73.958(4)° γ=81.354(4)°
<i>threo</i>-Diethyl 2-ethyl-2-hydroxy-3-(4-methylbenzenesulfonamido)succinate
C17H25NO7S
Acta Crystallographica Section E (2011) 67, 8 o2181-o2182
a=9.5424(3)Å b=12.2708(4)Å c=18.2427(5)Å
α=90.800(2)° β=91.153(2)° γ=112.513(3)°
(2R,4S,5R)-3-tert-butyl-2-ethyl-4,5-diphenyl- [1,3,2]-oxazaphospholidine2-oxide
C20H26NO2P
Acta Crystallographica Section B (2008) 64, 2 196-205
a=10.5381(8)Å b=15.7519(14)Å c=22.626(2)Å
α=90° β=90° γ=90°
(2R,4R,5S)-3-tert-butyl-2-[(1R)-1-methyl-2-oxo- propyl]-4,5-diphenyl-[1,3,2]-oxazaphospholidine2-oxide
C22H28N1O3P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=12.109(3)Å b=14.047(3)Å c=13.206(6)Å
α=90° β=111.48(3)° γ=90°